Ottawa Hospital Research Institute

From Wikipedia, the free encyclopedia
  (Redirected from OHRI)
Jump to: navigation, search

The Ottawa Hospital Research Institute (OHRI) is a non-profit academic health research institute located in Canada’s capital city of Ottawa. The OHRI’s vision is: to give our patients and their loved ones new hope through research that is making tomorrow's health care possible today. As of February 2006, the OHRI houses approximately 550 scientists and clinical investigators, 475 students and research fellows, and 700 support staff. The OHRI is an Affiliated Research Institute of the University of Ottawa and performs scientific research for The Ottawa Hospital in its efforts to discover new therapies. The name was changed in 2009 to the Ottawa Hospital Research Institute to reflect this role as the research arm of The Ottawa Hospital.

Research Programs[edit]

Research at OHRI is focused on answering important health questions and translating new findings into benefits for patients and society. Research at OHRI spans the full spectrum of health science, from basic molecular biology and epidemiology, to clinical trials and the development of new therapies, to health services and knowledge translation research. Research at OHRI is organized into six major programs (Cancer Therapeutics, Chronic Disease, Clinical Epidemiology, Neuroscience, Regenerative Medicine, Vision), with three cross-cutting strategic research areas (Regenerative and Biological Therapeutics, Practice-Changing Research and Vascular Health).

Evolution of the institute[edit]

Ronald G. Worton founded the OHRI as CEO and Scientific Director in 2001 following the merger of three Ottawa hospitals. Since then, external funding from grants and contracts has increased from $30 million to over $80 million Canadian (2012/13 fiscal year). In 2007, Duncan Stewart, formerly Chief Cardiologist of St. Michael's Hospital in Toronto and Director of Cardiology of University of Toronto, took over as CEO and Scientific Director after the retirement of Ronald Worton. Dr. Stewart's interests lie in translational research, which involves bringing therapeutic strategies developed in the lab, to reality at the bedside.

External links[edit]